COO logo

COO The Cooper Companies, Inc.

NASDAQ Global Select · Medical - Instruments & Supplies · Healthcare

$58.88
-1.45 (-2.40%)

The Cooper Companies, Inc. (COO) operates as a global medical device firm, primarily focused on developing, producing, and distributing products through two distinct business units: CooperVision and CooperSurgical. CooperVision specializes in contact lenses. Their product range includes spherical lenses for common vision issues like nearsightedness and farsightedness, as well as advanced lenses su…

Market Cap: $11.20Bwww.coopercos.com

Price

$76.22+1.94%
$58.98$67.43$75.87$84.32
Jul 2025Aug 2026

Social Signal Score

39
5d
—
30d
48
3 mentions
+0.0%
60d
28
12 mentions
+0.0%
90d
39
35 mentions
+0.0%
news: 30 · marketaux: 2 · rss: 3

Analyst Ratings

28 analysts
Buyconsensus
Strong Buy 0Buy 14Hold 13Sell 1Strong Sell 0
Avg price target$65.11+10.6%
Low $59Median $61High $75
Current Consensus

52-week range

$58.98$84.32
Last close
$76.22
Off 52w high
-9.6%
200-day average
$73.35
vs 200-day
+3.9%

Revenue

$1.07B+105.57%
$499.10M$693.23M$887.37M$1.08B
Oct 2016Jul 2026

Analyst Estimates

FY2025
$4.10
$4.09–$4.11
12 analysts
FY2026
$4.53+11% YoY
$4.52–$4.54
11 analysts
FY2027
$4.68+3% YoY
$4.54–$4.87
11 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
Albert G. White
Sector
Healthcare
Industry
Medical - Instruments & Supplies
Employees
15,000
Beta
0.82
Country
US
Piotroski score
7 / 9 (Strong)
Altman Z-score
2.95
www.coopercos.com